196 related articles for article (PubMed ID: 15252835)
61. Disruption of CTCF at the miR-125b1 locus in gynecological cancers.
Soto-Reyes E; González-Barrios R; Cisneros-Soberanis F; Herrera-Goepfert R; Pérez V; Cantú D; Prada D; Castro C; Recillas-Targa F; Herrera LA
BMC Cancer; 2012 Jan; 12():40. PubMed ID: 22277129
[TBL] [Abstract][Full Text] [Related]
62. Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population.
Arif T; Anwar N
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2395-2401. PubMed ID: 32856871
[TBL] [Abstract][Full Text] [Related]
63. Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer.
Suijkerbuijk KP; Fackler MJ; Sukumar S; van Gils CH; van Laar T; van der Wall E; Vooijs M; van Diest PJ
Ann Oncol; 2008 Nov; 19(11):1870-4. PubMed ID: 18647968
[TBL] [Abstract][Full Text] [Related]
64. In vivo footprint and methylation analysis by PCR-aided genomic sequencing: comparison of active and inactive X chromosomal DNA at the CpG island and promoter of human PGK-1.
Pfeifer GP; Tanguay RL; Steigerwald SD; Riggs AD
Genes Dev; 1990 Aug; 4(8):1277-87. PubMed ID: 2227409
[TBL] [Abstract][Full Text] [Related]
65. Positive display of methylated sites: a novel method for the detection of promoter methylation.
Lilischkis R; Kneitz H; Lehmann U; Kreipe H
Diagn Mol Pathol; 2000 Sep; 9(3):165-71. PubMed ID: 10976724
[TBL] [Abstract][Full Text] [Related]
66. BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene.
Abramovitch S; Glaser T; Ouchi T; Werner H
FEBS Lett; 2003 Apr; 541(1-3):149-54. PubMed ID: 12706836
[TBL] [Abstract][Full Text] [Related]
67. BRCA1 promoter hypermethylation and protein expression in ovarian carcinoma--an Indian study.
Shilpa V; Bhagat R; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
Tumour Biol; 2014 May; 35(5):4277-84. PubMed ID: 24385383
[TBL] [Abstract][Full Text] [Related]
68. DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells.
Tian HP; Lun SM; Huang HJ; He R; Kong PZ; Wang QS; Li XQ; Feng YM
J Biol Chem; 2015 Jul; 290(31):19173-83. PubMed ID: 26070560
[TBL] [Abstract][Full Text] [Related]
69. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island.
Macleod D; Charlton J; Mullins J; Bird AP
Genes Dev; 1994 Oct; 8(19):2282-92. PubMed ID: 7958895
[TBL] [Abstract][Full Text] [Related]
70. Regulation of BRCA1 expression and its relationship to sporadic breast cancer.
Mueller CR; Roskelley CD
Breast Cancer Res; 2003; 5(1):45-52. PubMed ID: 12559046
[TBL] [Abstract][Full Text] [Related]
71. BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer.
Otani Y; Miyake T; Kagara N; Shimoda M; Naoi Y; Maruyama N; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Cancer Sci; 2014 Oct; 105(10):1369-76. PubMed ID: 25155055
[TBL] [Abstract][Full Text] [Related]
72. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF.
De La Rosa-Velázquez IA; Rincón-Arano H; Benítez-Bribiesca L; Recillas-Targa F
Cancer Res; 2007 Mar; 67(6):2577-85. PubMed ID: 17363576
[TBL] [Abstract][Full Text] [Related]
73. The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer.
Wang D; Li C; Zhang X
DNA Cell Biol; 2014 Sep; 33(9):581-90. PubMed ID: 24842653
[TBL] [Abstract][Full Text] [Related]
74. Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.
Wong EM; Southey MC; Fox SB; Brown MA; Dowty JG; Jenkins MA; Giles GG; Hopper JL; Dobrovic A
Cancer Prev Res (Phila); 2011 Jan; 4(1):23-33. PubMed ID: 20978112
[TBL] [Abstract][Full Text] [Related]
75. Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation.
Wicki R; Franz C; Scholl FA; Heizmann CW; Schäfer BW
Cell Calcium; 1997 Oct; 22(4):243-54. PubMed ID: 9481475
[TBL] [Abstract][Full Text] [Related]
76. Detection of hypermethylation BRCA1/2 gene promoter in breast tumours among Moroccan women.
Saif I; Bouziyane A; Benhessou M; Karroumi ME; Ennaji MM
Mol Biol Rep; 2021 Nov; 48(11):7147-7152. PubMed ID: 34591267
[TBL] [Abstract][Full Text] [Related]
77. Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patient.
Cai FF; Chen S; Wang MH; Lin XY; Zhang L; Zhang JX; Wang LX; Yang J; Ding JH; Pan X; Shao ZM; Biskup E
Oncotarget; 2016 May; 7(19):27499-510. PubMed ID: 27027444
[TBL] [Abstract][Full Text] [Related]
78. Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology.
Pal R; Srivastava N; Chopra R; Gochhait S; Gupta P; Prakash N; Agarwal G; Bamezai RN
Mol Cancer; 2010 Nov; 9():303. PubMed ID: 21092294
[TBL] [Abstract][Full Text] [Related]
79. Transcription of BRCA1 is dependent on the formation of a specific protein-DNA complex on the minimal BRCA1 Bi-directional promoter.
Suen TC; Goss PE
J Biol Chem; 1999 Oct; 274(44):31297-304. PubMed ID: 10531328
[TBL] [Abstract][Full Text] [Related]
80. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.
Holm K; Hegardt C; Staaf J; Vallon-Christersson J; Jönsson G; Olsson H; Borg A; Ringnér M
Breast Cancer Res; 2010; 12(3):R36. PubMed ID: 20565864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
